April 29, 2021Journal of Cardiovascular Medicine
Pericarditis in patients with COVID-19: a systematic review
Key result
Among 34 patients with COVID-19 and pericarditis, overall in-hospital mortality was 6%, with no significant difference between patients with acute pericarditis and myopericarditis.
Why the study?
To summarize the clinical features, diagnostic methods, treatment, and outcomes of COVID-19 patients with pericarditis.
What are the clinical features, treatments, and outcomes of patients with COVID-19 and pericarditis?
Population
34 COVID-19 patients with pericarditis across 33 studies
Comparison
Patients with acute pericarditis vs myopericarditis
Design
Systematic review of 32 case reports and 1 case series
Authors
Discussion
Loading...
Member takes
Implication
Favorable short-term prognosis in this rare COVID-19 complication; leaves open need for larger prospective studies on management.
Study Design
Type
Systematic Review (n=34)
Structured PICO
What are the clinical features, treatments, and outcomes of patients with COVID-19 and pericarditis?
P
Population
34 patients with COVID-19 and pericarditis included from 33 studies (mostly case reports) to summarize clinical features and outcomes.
O
Outcome
Clinical features, diagnostic methods, treatment, and outcomes (including in-hospital mortality)
COVID-19 patients with pericarditis present with clinical features similar to other viral cardiotropic infections, often complicated by myopericarditis and effusion, but generally have a good short-term prognosis.
Cite This Study
Diaz‐Arocutipa et al. (2021) conducted a systematic review in COVID-19 and pericarditis (n=34). Acute pericarditis vs. Myopericarditis was evaluated on In-hospital mortality. Among 34 patients with COVID-19 and pericarditis, overall in-hospital mortality was 6%, with no significant difference between patients with acute pericarditis and myopericarditis.